Security
Aurinia Pharmaceuticals Inc. · COM
9 owners max 0.0% (Two Sigma Investments, LP)
owners
9
max %
0.0%
tracked value
$153M
qoq
A 5
R 3
holders
sorted by % of portfolio · long equity only
| manager | % port | activity | shares | value | history |
|---|---|---|---|---|---|
| Two Sigma Investments, LP 2025 Q4 stale | 0.0% | Exit -0.04 pp | 1,962,742 | $31M | hist |
| Renaissance Technologies LLC 2026 Q1 | 0.0% | Add 0.00 pp | 1,663,835 | $25M | hist |
| Marshall Wace - Marshall Wace, LLP 2026 Q1 | 0.0% | Add 0.00 pp | 1,874,597 | $28M | hist |
| D. E. Shaw & Co., Inc. 2026 Q1 | 0.0% | Add 0.00 pp | 1,572,983 | $23M | hist |
| Cliff Asness - Aqr Capital Management LLC 2026 Q1 | 0.0% | Add 0.00 pp | 948,810 | $14M | hist |
| Joel Greenblatt - Gotham Asset Management, LLC 2026 Q1 | 0.0% | Add 0.00 pp | 168,598 | $2M | hist |
| Vanguard Group Inc. 2025 Q4 stale | 0.0% | Reduce 0.00 pp | 1,449,884 | $23M | hist |
| Ken Griffin - Citadel Advisors LLC 2026 Q1 | 0.0% | Reduce 0.00 pp | 274,574 | $4M | hist |
| Israel Englander - Millennium Management LLC 2026 Q1 | 0.0% | Reduce 0.00 pp | 117,169 | $2M | hist |
No managers match this filter.
financials
US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing
Income statement
Balance sheet
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Total current assets | $424.8M | $446.6M | $491.97M |
| Total non-current assets * | $123.26M | $104.05M | $259.62M |
| Total assets | $548.06M | $550.64M | $751.59M |
| Total current liabilities | $77.19M | $97.76M | $93.72M |
| Total non-current liabilities * | $92.92M | $75.4M | $76.53M |
| Total equity | $377.95M | $377.48M | $581.33M |
ownership over time
filing count by report period · click a bar for that quarter’s holders